Intuitive reaches 10 million procedures performed using da



SUNNYVALE, Calif., December 14, 2021 (GLOBE NEWSWIRE) – Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and a pioneer in robot-assisted surgery, today announced that the number of procedures performed worldwide total by surgeons using da Vinci surgical systems has exceeded 10 million.

“Surgeons’ use of da Vinci surgical systems in more than 10 million procedures reflects the benefits that high-quality minimally invasive surgery brings to patients, families and the health systems that care for them,” said said Gary Guthart, CEO of Intuitive. “While we are proud of this step and momentum, it really is a time to look at what we have learned from these 10 million procedures and ask ourselves how we can apply this to improve the field of surgery for coming years. “

Cleared for use by the United States Food & Drug Administration in 2000, there are more than 6,500 da Vinci surgical systems installed in 67 countries, and more than 55,000 surgeons worldwide have been trained in the use of the da Vinci systems.

“We have always strived to provide solutions that meet the needs of our customers: better patient outcomes, better patient experiences, better healthcare team experiences and a lower total cost of treatment per patient episode.” , Guthart said. “We will continue to drive results-driven innovation for our clients to help their patients with the next 10 million procedures and beyond. “

Intuitif plans to continue to draw on its vast and extensive experience with these procedures and to bring it to the service of clients in the form of personalized surgical training programs, continuous innovation in systems, instruments and accessories, and an expanded ecosystem of customer services, development of evidence and support and digital solutions.

There are nearly 70 representative clinical uses for da Vinci systems, spanning clinical specialties including urology, gynecology, thoracic surgery, general surgery, and transoral surgery.

“The growing clinical evidence base – nearly 30,000 studies of robot-assisted surgery – and the growing ability of surgeons, hospitals and healthcare systems to assess their own data and patient outcomes, have been the primary drivers. the adoption of surgeons and the growth of procedures that follow, ”said Guthart. “Our customers are dedicated to the health and well-being of their patients – they don’t adopt and continue to use technology that doesn’t meet their needs. “

Intuitive’s latest and fourth generation robotic systems, the da Vinci X, Xi and its Single Port System (SP), have continued to evolve with technology, as well as the addition of instruments, functionality and digital support.

The company’s innovation in robot-assisted technology includes the development of its ionic endoluminal system designed to enable robotic-assisted lung biopsy.

About Intuitive

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., Is a global leader in minimally invasive care technology and the pioneer of robot-assisted surgery. As part of our mission, we believe that minimally invasive care is life-enhancing care. Through ingenuity and smart technology, we are expanding the potential of physicians to heal without constraints.

Intuitive brings more than two decades of leadership in robot-assisted surgical technology and solutions to its offerings and develops, manufactures and markets the da Vinci Surgical System and the Ion Endoluminal System.

Product and brand names / logos are trademarks or registered trademarks of Intuitive Surgical or their respective owners. See www.intuitive.com/trademarks.

For more information, please visit the company’s website at www.intuitive.com.

About the da Vinci Surgical System

There are several models of the da Vinci surgical system. Da Vinci Surgical Systems are designed to help surgeons perform minimally invasive surgery. Da Vinci systems provide surgeons with high definition 3D vision, magnified view, and robotic and computer support. They use specialized instruments, including a miniaturized surgical camera and wrist instruments (i.e. scissors, scalpels, and forceps) designed to aid in precise dissection and reconstruction deep within. from the body.

For more information, please visit the company’s website at www.intuitive.com.

About Ion

Ion is Intuitive’s robot-assisted platform for minimally invasive lung biopsy. The system includes an ultra-thin, ultra-maneuverable catheter that allows navigation far into the peripheral lung and provides the unprecedented stability needed for accurate biopsy. Visit www.intuitive.com/en-us/products-and-services/ion

Important safety information

For important safety information, directions for use, hazards, cautions, and full warnings, please refer to www.intuitive.com/safety.

Forward-looking statements

This press release contains forward-looking statements about Intuitive and our plans to continue to improve our products to advance minimally invasive surgery, which involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by. these statements. Risks and uncertainties include, among others, our ability to build on the strong clinical and technological base created, our ability to work to expand our capacity, our ability to invest for future innovation and growth, competitive developments and customer’s willingness to continue using our products. We assume no obligation to publicly update or publish revisions to these forward-looking statements, except as required by law.

Contact
UNITED STATES / WORLD: Global Public Affairs
Intuitive surgery
[email protected]
+ 1-202-997-7373
+ 1-470-331-0327


Previous The Kind of Engineering Education We Need
Next 4 million Coloradans vaccinated and it continues